|
1
|
Stubbs JR, House JA, Ocque AJ, Zhang S,
Johnson C, Kimber C, Schmidt K, Gupta A, Wetmore JB, Nolin TD, et
al: Serum trimethylamine-N-oxide is elevated in CKD and correlates
with coronary atherosclerosis burden. J Am Soc Nephrol. 27:305–313.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kaplan H, Thompson RC, Trumble BC, Wann
LS, Allam AH, Beheim B, Frohlich B, Sutherland ML, Sutherland JD,
Stieglitz J, et al: Coronary atherosclerosis in indigenous South
American Tsimane: A cross-sectional cohort study. Lancet.
389:1730–1739. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ughi GJ, Wang H, Gerbaud E, Gardecki JA,
Fard AM, Hamidi E, Vacas-Jacques P, Rosenberg M, Jaffer FA and
Tearney GJ: Clinical characterization of coronary atherosclerosis
with dual-modality OCT and near-infrared autofluorescence imaging.
JACC Cardiovasc Imaging. 9:1304–1314. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Akboga MK, Canpolat U, Yayla C, Ozcan F,
Ozeke O, Topaloglu S and Aras D: Association of platelet to
lymphocyte ratio with inflammation and severity of coronary
atherosclerosis in patients with stable coronary artery disease.
Angiology. 67:89–95. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nicholls SJ, Puri R, Wolski K, Ballantyne
CM, Barter PJ, Brewer HB, Kastelein JJ, Hu B, Uno K, Kataoka Y, et
al: Effect of the BET protein inhibitor, RVX-208, on progression of
coronary atherosclerosis: Results of the phase 2b, randomized,
double-blind, multicenter, ASSURE trial. Am J Cardiovasc Drugs.
16:55–65. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Barbato E, Toth GG, Johnson NP, Pijls NH,
Fearon WF, Tonino PA, Curzen N, Piroth Z, Rioufol G, Jüni P, et al:
A prospective natural history study of coronary atherosclerosis
using fractional flow reserve. J Am Coll Cardiol. 68:2247–2255.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Otsuka F, Yasuda S, Noguchi T and
Ishibashi-Ueda H: Pathology of coronary atherosclerosis and
thrombosis. Cardiovasc Diagn Ther. 6:396–408. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Furuhashi M, Fuseya T, Murata M, Hoshina
K, Ishimura S, Mita T, Watanabe Y, Omori A, Matsumoto M, Sugaya T,
et al: Local production of fatty acid-binding protein 4 in
epicardial/perivascular fat and macrophages is linked to coronary
atherosclerosis. Arterioscler Thromb Vasc Biol. 36:825–834. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Koskinas KC, Windecker S and Räber L:
Regression of coronary atherosclerosis: Current evidence and future
perspectives. Trends Cardiovasc Med. 26:150–161. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thondapu V, Bourantas CV, Foin N, Jang IK,
Serruys PW and Barlis P: Biomechanical stress in coronary
atherosclerosis: Emerging insights from computational modelling.
Eur Heart J. 38:81–92. 2017.PubMed/NCBI
|
|
11
|
Afrasyab A, Qu P, Zhao Y, Peng K, Wang H,
Lou D, Niu N and Yuan D: Correlation of NLRP3 with severity and
prognosis of coronary atherosclerosis in acute coronary syndrome
patients. Heart Vessels. 31:1218–1229. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dijk W and Kersten S: Regulation of lipid
metabolism by angiopoietin-like proteins. Curr Opin Lipidol.
27:249–256. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hata J, Mukai N, Nagata M, Ohara T,
Yoshida D, Kishimoto H, Shibata M, Hirakawa Y, Endo M, Ago T, et
al: Serum Angiopoietin-Like protein 2 is a novel risk factor for
cardiovascular disease in the community: The Hisayama study.
Arterioscler Thromb Vasc Biol. 36:1686–1691. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Morinaga J, Kadomatsu T, Miyata K, Endo M,
Terada K, Tian Z, Sugizaki T, Tanigawa H, Zhao J, Zhu S, et al:
Angiopoietin-like protein 2 increases renal fibrosis by
accelerating transforming growth factor-β signaling in chronic
kidney disease. Kidney Int. 89:327–341. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shimomura M, Oyama J, Takeuchi M, Shibata
Y, Yamamoto Y, Kawasaki T, Komoda H, Kodama K, Sakuma M, Toyoda S,
et al: Acute effects of statin on reduction of angiopoietin-like 2
and glyceraldehyde-derived advanced glycation end-products levels
in patients with acute myocardial infarction: A message from SAMIT
(Statin for Acute Myocardial Infarction Trial). Heart Vessels.
31:1583–1589. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liberale L, Bonaventura A, Vecchiè A,
Matteo C, Dallegri F, Montecucco F and Carbone F: The role of
adipocytokines in coronary atherosclerosis. Curr Atheroscler Rep.
19:102017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheng JM, Oemrawsingh RM, Garcia-Garcia
HM, Boersma E, van Geuns RJ, Serruys PW, Kardys I and Akkerhuis KM:
PCSK9 in relation to coronary plaque inflammation: Results of the
ATHEROREMO-IVUS study. Atherosclerosis. 248:117–122. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dursunoglu N, Dursunoglu D, Yıldız AI,
Uludag B, Alaçam ZN and Sarıçopur A: Severity of coronary
atherosclerosis in patients with COPD. Clin Respir J. 11:751–756.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Amadatsu T, Morinaga J, Kawano T, Terada
K, Kadomatsu T, Miyata K, Endo M, Kasamo D, Kuratsu JI and Oike Y:
Macrophage-derived angiopoietin-like protein 2 exacerbates brain
damage by accelerating acute inflammation after
ischemia-reperfusion. PLoS One. 11:e01662852016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hirasawa M, Takubo K, Osada H, Miyake S,
Toda E, Endo M, Umezawa K, Tsubota K, Oike Y and Ozawa Y:
Angiopoietin-like protein 2 is a multistep regulator of
inflammatory neovascularization in a murine model of age-related
macular degeneration. J Biol Chem. 291:7373–7385. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Reed GW, Rossi JE and Cannon CP: Acute
myocardial infarction. Lancet. 389:197–210. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li C, Li C, Yue J, Huang X, Chen M, Gao J
and Wu B: miR-21 and miR-101 regulate PLAP-1 expression in
periodontal ligament cells. Mol Med Rep. 5:1340–1346.
2012.PubMed/NCBI
|
|
23
|
Taketani Y, Usui T, Toyono T, Shima N,
Yokoo S, Kimakura M, Yamagami S, Ohno S, Onodera R, Tahara K, et
al: Topical use of angiopoietin-like protein 2 RNAi-loaded lipid
nanoparticles suppresses corneal neovascularization. Mol Ther
Nucleic Acids. 5:e2922016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bobryshev YV, Ivanova EA, Chistiakov DA,
Nikiforov NG and Orekhov AN: Macrophages and their role in
atherosclerosis: pathophysiology and transcriptome analysis. BioMed
Res Int. 2016:95824302016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Biscetti F, Straface G, Porreca CF,
Bertoletti G, Vincenzoni C, Snider F, Stigliano E, Arena V,
Angelini F, Pecorini G, et al: Increased FGF23 serum level is
associated with unstable carotid plaque in type 2 diabetic subjects
with internal carotid stenosis. Cardiovasc Diabetol. 14:1392015.
View Article : Google Scholar : PubMed/NCBI
|
